Need to improve the treatment of cardiovascular risk factors in type 2 diabetic patients with nephropathy.

被引：0
|
作者：
Carrera, MJ
Gómez, N
Micaló, T
Sahún, M
Vinzia, C
Montanya, E
Prat, CAP
机构：
[1] Bellvitge Hosp, CSUB, Barcelona, Spain
[2] H Viladecans, Hosp, Barcelona, Spain
来源：
DIABETOLOGIA | 1998年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1128
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [21] Analyses of cardiovascular risk factors in offsprings of type 2 diabetic patients
    Gürlek, A
    Bayraktar, M
    DIABETOLOGIA, 1999, 42 : A286 - A286
  • [22] Dyslipidaemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy
    Martínez-Castelao, A
    Ramos, R
    González, MT
    Castiñeiras, MJ
    NEFROLOGIA, 2002, 22 : 51 - 58
  • [23] Lack of management of cardiovascular risk factors in type 2 diabetic patients
    Yun, K. E.
    Park, M. J.
    Park, H. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (01) : 39 - 44
  • [24] Cardiovascular risk factors in type 2 diabetic patients in Libreville, Gabon
    Ovono, A. F.
    Bekale, S.
    Fernandez, J.
    Mbang, B. A.
    Ngou-Milama, E.
    AFRICAN JOURNAL OF DIABETES MEDICINE, 2011, 19 (02): : 12 - 14
  • [25] Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients
    Chen, H. -S.
    Wu, T. -E. J.
    Jap, T. -S.
    Lu, R. -A.
    Wang, M. -L.
    Chen, R. -L.
    Lin, H. -D.
    DIABETIC MEDICINE, 2007, 24 (12) : 1336 - 1344
  • [26] A Study on Prevalence and Risk Factors of Diabetic Nephropathy in Newly Detected Type 2 Diabetic Patients
    Ravindran, Rahul
    Kalaivalli, S.
    Srinivasagalu, S.
    Karthik, Lakshminarayanan
    JOURNAL OF DIABETOLOGY, 2020, 11 (02) : 109 - 114
  • [27] ACE inhibitors in treatment of adolescent patients with IDDM and diabetic nephropathy.
    Sokolovskaya, VN
    Sivoous, GI
    Voichik, EA
    Kasatkina, EP
    DIABETOLOGIA, 1997, 40 : 2141 - 2141
  • [28] Monitoring and management of cardiovascular risk factors in patients with advanced diabetic nephropathy
    Kashif, M.
    Gulfam, T.
    Aslam, M. W.
    Mada, S.
    DIABETIC MEDICINE, 2015, 32 : 106 - 107
  • [29] Risk factors for progression of IgA nephropathy.
    Wu, QQ
    Yang, NS
    Li, YJ
    Yang, X
    Yu, XQ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 809A - 810A
  • [30] The prognostic relevance of histological score (HS evaluation in patients with type 2 diabetic nephropathy.
    Bertani, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 250A - 250A
12345